This page is intended for UK healthcare professionals only

This section of the website is currently undergoing maintenance. We are working to resolve this as soon as possible, please check back shortly.

For ELIQUIS® (apixaban) Prescribing Information and
Adverse Event reporting information, Click here

To access the ELIQUIS Summary of Product Characteristics (smPC), please Click here

432-GB-2100072 | Date of preparation: October 2021